Hospitalization rates differ by hepatitis C satus in an urban HIV cohort.
about
Therapeutic issues in HIV/HCV-coinfected patientsSevere morbidity according to sex in the era of combined antiretroviral therapy: the ANRS CO3 Aquitaine CohortAIDS and non-AIDS severe morbidity associated with hospitalizations among HIV-infected patients in two regions with universal access to care and antiretroviral therapy, France and Brazil, 2000-2008: hospital-based cohort studiesInpatient health services utilization among HIV-infected adult patients in care 2002-2007.Relationships between cellular immune responses and treatment outcomes with interferon and ribavirin in HIV/hepatitis C virus co-infection.Hospitalizations in a cohort of HIV patients in Australia, 1999-2007Trends and causes of hospitalizations among HIV-infected persons during the late HAART era: what is the impact of CD4 counts and HAART use?Hepatitis C and the risk of kidney disease and mortality in veterans with HIVEmergency department utilization among HIV-infected patients in a multisite multistate studyHospitalization risk following initiation of highly active antiretroviral therapyNational trends in hospitalization and mortality rates for patients with HIV, HCV, or HIV/HCV coinfection from 1996-2010 in the United States: a cross-sectional studyCurrent practices of screening for incident hepatitis C virus (HCV) infection among HIV-infected, HCV-uninfected individuals in primary care.HIV infection in the elderlyImpact of hepatitis coinfection on healthcare utilization among persons living with HIV.Buprenorphine and buprenorphine/naloxone diversion, misuse, and illicit use: an international review.Hospitalization Rates and Reasons Among HIV Elite Controllers and Persons With Medically Controlled HIV Infection.The association of HIV viral load with indirect markers of liver injury.Trends in reasons for hospitalization in a multisite United States cohort of persons living with HIV, 2001-2008.New hopes for HIV and HCV coinfection in 2004.Treatment of HIV infection in the older patient.Acute hepatitis C in persons infected with the human immunodeficiency virus (HIV): the "real-life setting" proves the concept.Alcohol-Related Diagnoses and All-Cause Hospitalization Among HIV-Infected and Uninfected Patients: A Longitudinal Analysis of United States Veterans from 1997 to 2011.Design and feasibility of a randomized behavioral intervention to reduce distributive injection risk and improve health-care access among hepatitis C virus positive injection drug users: the Study to Reduce Intravenous Exposures (STRIVE).Contemporary costs of HIV healthcare in the HAART eraThe burden of hepatitis C virus infection is growing: a Canadian population-based study of hospitalizations from 1994 to 2004.Risk factors for liver fibrosis among human immunodeficiency virus monoinfected patients using the FIB4 index in Morocco.Co-infection of hepatitis B and hepatitis C virus in human immunodeficiency virus-infected patients in New York City, United States.Hospitals as a 'risk environment': an ethno-epidemiological study of voluntary and involuntary discharge from hospital against medical advice among people who inject drugsImpact of hepatitis coinfection on hospitalization rates and causes in a multicenter cohort of persons living with HIV.Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study.Inhibition of HCV by the serpin antithrombin IIINonadherence increases the risk of hospitalization among HIV-infected antiretroviral naive patients started on HAART.Predicting hospitalization among HIV-infected antiretroviral naïve patients starting HAART: determining clinical markers and exploring social pathways.Psychosocial correlates of HIV-monoinfection and HIV/HCV-coinfection among men who have sex with men.Quality of life, symptomatology and healthcare utilization in HIV/HCV co-infected drug users in Miami.
P2860
Q27481053-D5779212-CC55-47AF-AAE2-40A1E8FE221BQ28541356-1E6C496D-9ABB-4413-B43B-4FA01B1F9C9EQ33656320-439ABCCA-C3F1-4FEB-B1B1-3AF258D0C8E6Q33699011-DE832250-9810-487E-BC56-4E757EB048ADQ33767267-DBD5D92F-95E8-4413-8BA7-A1DA8B966E9AQ33924662-0184509A-667F-4B20-B2B5-80DF98A76500Q34027867-322278E1-22B4-4C15-9DE6-2197BC3FFDE4Q34546552-3BBCF4F8-5C42-400D-BD18-A82D024D1A90Q34774857-289247BC-6CA0-45D2-B9D8-87895814EF79Q34802635-7875BC8A-31DE-4B3E-9EFC-8EA5C4C9E759Q34873781-F8B29330-172B-4133-9BF8-EC003EA96724Q35029328-EEDDB828-ECF8-4F78-8421-6F17E3DABAEAQ35086332-C2120995-BF65-46E4-84EC-8E195D0566A3Q35106985-D7EAE411-EF13-42D1-ABE0-DC17E9C247E9Q35160035-8EF659A2-4DF4-4959-928C-052C680904A5Q35661912-4419D2CC-F90D-4DB5-BCC8-053EE582EDE1Q35681714-CB2D89CD-DC96-4D96-B6AC-43541A4FB961Q35823411-F4800CBC-02D2-4CB3-B72E-78355A1E6677Q35912407-1235694D-E506-4445-AB86-AA3A81E279D7Q35917538-8CCB0263-8C0B-4D65-B260-235A89A86282Q35959954-509BB17C-6E5B-4AAD-B12B-4FD70C1228FAQ35998519-B529F485-C4C7-494F-A612-B76ACE4128E9Q36144776-446B867C-B6A6-4B30-B2CC-4FBFA5CE35CCQ36550975-DAA42E54-C8C9-4BF4-B6F0-F7A1B860B0A4Q37144257-8EAAE276-AAF0-4018-B1B9-EAD2B5847682Q37266335-5521794B-4FAF-46B4-A4BD-922811228741Q37335253-588FF650-B5C3-4D48-AC1B-1ED7014F35DDQ37633523-D6AB7208-F25A-4B2C-ABEE-258E63754657Q37706753-34F5E747-D0B1-4D17-82D5-E3D6C348BAB7Q41524630-730F35DF-F582-4E8A-99CF-A1FA132DE08FQ42406960-4FA013EE-930C-4166-A189-78054364212FQ44911263-4623EE56-EB3E-4E8C-B7BF-21B4E8835845Q46943291-FDBB0C1F-3C11-4F26-BC2B-D323B6F4DCDEQ46955676-6E8FC29B-64D8-434B-B6AA-ACB3FFAD8B01Q47593228-29EC0280-F110-41EF-9024-43FB338C09ED
P2860
Hospitalization rates differ by hepatitis C satus in an urban HIV cohort.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Hospitalization rates differ by hepatitis C satus in an urban HIV cohort.
@en
Hospitalization rates differ by hepatitis C satus in an urban HIV cohort.
@nl
type
label
Hospitalization rates differ by hepatitis C satus in an urban HIV cohort.
@en
Hospitalization rates differ by hepatitis C satus in an urban HIV cohort.
@nl
prefLabel
Hospitalization rates differ by hepatitis C satus in an urban HIV cohort.
@en
Hospitalization rates differ by hepatitis C satus in an urban HIV cohort.
@nl
P2093
P1476
Hospitalization rates differ by hepatitis C satus in an urban HIV cohort.
@en
P2093
Kelly A Gebo
Marie Diener-West
Richard D Moore
P304
P356
10.1097/00126334-200310010-00006
P407
P577
2003-10-01T00:00:00Z